Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors

Withdrawn before enrolling · Not applicable

Conditions studied: Breast Cancer, Cancer Survivor, Cognitive/Functional Effects

In brief

This randomized clinical trial studies cognitive enhancement program in improving cognitive function in breast cancer survivors. A cognitive enhancement program may help improve cognitive function in breast cancer survivors and may help doctors plan better treatment for cognitive decline.

Key facts

Study ID

NCT02166983

Run by

Stanford University

People needed

0

Starts

2014-01-01

Last updated by the study team

2014-11-24

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Previous diagnosis of breast cancer
• Received chemotherapy treatment for breast cancer diagnosis
• Chemotherapy-free for at least one year

You may not qualify if…

• History of learning disability, head trauma, neurologic disorder or significant psychiatric condition
• Significant medical condition (e.g. diabetes) unrelated to cancer diagnosis
• Magnetic resonance imaging (MRI) contraindications (e.g. metallic biomedical implants)
• Pregnancy

Where it is running

• Stanford University Hospitals and Clinics — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.